Isolated ultrafiltration in heart failure patients

Current Cardiology Reports

Volumn 14, Issue 3, 2012, Pages 254-264

  Costanzo, Maria Rosa ^a   Ronco, Claudio ^b  

^a Midwest Heart Foundation   (United States)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Cardiorenal syndrome; Fluid overload; Heart failure; Ultrafiltration

Indexed keywords

ALDOSTERONE ANTAGONIST; ARGATROBAN; CHLOROTHIAZIDE; DIURETIC AGENT; FUROSEMIDE; HEPARIN; LOOP DIURETIC AGENT; METOLAZONE; NESIRITIDE;

ANTICOAGULATION; APHERESIS; AQUAPHERESIS; ARTICLE; BLOOD VOLUME; CONTINUOUS INFUSION; EDEMA; ELECTROLYTE DISTURBANCE; FILTERS AND MEMBRANES; FLUID TRANSPORT; HEALTH CARE COST; HEARING LOSS; HEART FAILURE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPOTENSION; OSTEOLYSIS; PATIENT SELECTION; PHOTOSENSITIVITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECOMMENDED DRUG DOSE; SIDE EFFECT; SODIUM ABSORPTION; THROMBOSIS; TREATMENT CONTRAINDICATION; ULTRAFILTRATION; VASCULAR ACCESS; VENO VENOUS ULTRAFILTRATION;

CARDIO-RENAL SYNDROME; DIURETICS; HEART FAILURE; HEMOFILTRATION; HUMANS; MEMBRANES, ARTIFICIAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WATER-ELECTROLYTE IMBALANCE;

EID: 84861097584     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-012-0257-y     Document Type: Article

References (54)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart Disease and Stroke Statistics-2010 update. A report from the American Heart Association Statistics. Circulation. 2010;121:e46-e215. According to this Heart Disease Update from the AHA number of hospitalizations for HF decompensation exceeds 1.2 million per year.
2. Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-16.
3. Jain P, Massie BM, Gattis WA, et al. Current medical treatment for exacerbation of chronic heart failure resulting in hospitalization. Am Heart J. 2003;145:S3-S17.
4. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345:574-81.
5. Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-9.
6. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422-30.
7. Ronco C, Haapio M, House A, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527-39.
8. Felker GM, Lee KL, Bull DA, et al. Diuretic strategies evaluation in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797-805.
9. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. N Engl J Med. 1974;291:747-51.
10. Henderson LW, Lilley JJ, Ford CA, Stone RA. Hemodiafiltration. J Dial. 1977;1(3):211-38.
11. Nalesso F, Garzotto F, Ronco C. Technical aspects of extracorporeal ultrafiltration: mechanisms, monitoring and dedicated technology. Contrib Nephrol. 2010;164:199-208. This is a comprehensive review of UF methods spanning from isolated UF to extracorporeal fluid removal in the settings of hemodiafiltration and dialysis..
12. Ricci Z, Bonello M, Salvatori G, et al. Continuous renal replacement technology: from adaptive technology and early dedicated machines towards flexible multipurpose machine platforms. Blood Purif 2004;22(3):269-76.
13. Jaski BE, Ha J, Denys BG, Lamba S, Trupp RJ, Abraham WT Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail. 2003;9:227-31.
14. Ronco C, Ricci Z, Bellomo R, Bedogni F. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology. 2001;96:155-68.
15. Clark WR, Macias WL, Molitoris BA, Wang NH. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int. 1995;48:481-88.
16. Clark WR, Hamburger RJ, Lysaght MJ. Effect of membrane composition and structure on solute removal and biocompatility in hemodialysis. Kidney Int. 1999;56:2005-15.
17. Ronco C, Brendolan A, Bellomo R. On-line monitoring in continuous renal replacement therapies. Kidney Int. 1999;56 suppl 72:S8-S14.
18. Ward RA, Ronco C. Improvements in technology: a path to safer and more effective hemodialysis. Blood Purif. 2009;27:6-10.
19. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-85.
20. Ellison DH, Velazquez H, Wright FS. Adaptation of the distal convoluted tubule of the rat: structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest. 1989;83:113-26.
21. Marenzi GC, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni PG Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol. 2001;38:963-8.
22. Asaba H, Bergstrom J, Furst P, et al. Treatment of diuretic-resistant fluid retention with ultrafiltration. Acta Med Scand. 1978;204:145-9.
23. Fauchald P, Forfang K, Amlie J. An evaluation of ultrafiltration as treatment of therapy-resistant cardiac edema. Acta Med Scand. 1986;219:47-52.
24. Donato L, Biagini, Contini C, et al. Treatment of end-stage congestive heart failure by extracorporeal ultrafiltration. Am J Cardiol. 1987;59:379-80.
25. Rimondini A, Cipolla CM, Della Bella P, et al. Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med. 1987;83:43-8.
26. Di Leo M, Pacitti A, Bergerone S, et al. Ultrafiltration in the treatment of refractory congestive heart failure. Clin Cardiol. 1988;11:449-52.
27. Simpson IA, Simpson K, Rae AP, et al. Ultrafiltration in diuretic resistant heart failure. Ren Fail. 1987;10:115-9.
28. Akiba T, Taniguchi K, Marumo F, Matsuda O, et al. Clinical significance of renal hemodynamics in severe congestive heart failure: responsiveness to ultrafiltration therapies. Jpn Circ J. 1989;53:191-6.
29. Cipolla CM, Grazi S, Rimondini A, et al. Changes in circulating norepinephrine with hemofiltration in advanced heart failure. Am J Cardiol. 1990;66:987-94.
30. Marenzi G, Grazi S, Giraldi F, et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med. 1993;94:49-56.
31. Agostoni PG, Marenzi GC, Lauri GF, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med. 1994;96:191-9.
32. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol. 2005;46:2047-51.
33. Bart BA, Boyle A, Bank AJ, et al. Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: relief for acutely fluid overloaded patients with decompensated congestive heart failure. J Am Coll Cardiol. 2005;46:2043-6.
34. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675-83.
35. Costanzo MR, Saltzberg MT, Jessup M, et al. Ultrafiltration is associated with fewer re-hospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail. 2010;16:277-84. This analysis preformed in the UNLOAD population shows that despite similar fluid loss by UF and IV diuretics administered by continuous infusion, HF events were reduced only in the UF group. This finding suggests that removal of isotonic fluid by UF may be superior to removal of hypotonic urine by IVdiuretics..
36. Ali SS, Olinger CC, Sobotka PA, et al. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail. 2009;15:1-4.
37. Konstam MA, Gheorghiade M, Burnett JC, for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Investigators, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure. The EVEREST outcome trial. JAMA. 2007;297:1319-31.
38. Abdallah JG, Schreier RW, Edelstein C, et al. Loop diuretic infusion increases thiazide-sensitive Na+/Cl-cotransporter abundance: role of aldosterone. J Am Soc Nephrol. 2001;12:1335-41.
39. Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-96. The findings reported in this manuscript confirm and expand the knowledge that central venous pressure influences renal function more than other hemodynamic values, including blood pressure, pulmonary artery wedge pressure, and cardiac index..
40. Jessup M, Costanzo MR. The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol. 2009;53:597-9. The authors of this editorial provide a possible explanation of the effects of central venous pressure on renal function: increase in central venous pressure is transmitted to the renal veins and eventually to the efferent arteriolar system of the kidney. This results in a decrease in net filtration pressure and glomerular filtration rate..
41. Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, et al. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail. 2008;14:1-5.
42. Bartone C, Saghir S, Menon SG, et al. Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure. Congest Heart Fail. 2008;14:298-301.
43. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122(3):265-72. This very provocative analysis of the ESCAPE trial population shows that patients who develop hemoconcentration have substantially improved survival despite a higher incidence of worsening renal function. These observations suggest that aggressive decongestion of patients with ADHF may improve survival, even when high diuretic doses are required or renal function deteriorates..
44. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;119:1977-2016.
45. Howlett JG, McKelvie RS, Costigan J, et al. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol. 2010;26:185-202.
46. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J. 2008;29:2388-442.
47. Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12:423-33. This expert consensus manuscript proposes a grading of congestion based on multiple clinical and biomarker values and suggests that a congestion score greater than 12 may warrant treatment with UF..
48. Hook KM, Abrams CS. Treatment options in heparin-induced thrombocytopenia. Curr Opin Hematol. 2010;17:424-31.
49. http://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfm?db= pmn&id=K040489. Accessed September 21, 2011
50. Bradley SM, Levy WC, Veenstra DL. Cost-consequences of ultrafiltration in acute heart failure: a decision model analysis. Circ Cardiovasc Qual Outcomes. 2009;2:566-73.
51. Setoguchi S, Stevenson LW. Hospitalizations in patients with heart failure: who and why. J Am Coll Cardiol. 2009;54:1703-5.
52. Ricci Z, Ronco C, D'amico G, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant. 2006;21(3):690-6.
53. Ronco C, Davenport A, Gura V. The future of the artificial kidney: moving towards wearable and miniaturized devices. Nefrologia. 2011;3:9-16.
54. Ronco C, Davenport A, Gura V. A wearable artificial kidney: dream or reality? Nat Clin Pract Nephrol. 2008;4:604-5.